Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: EgyiptomFázis nélkül

Efficacy of Combined Endoscopic Third Ventriculostomy and Choroid Plexus Cauterization in Treatment of Hydrocephalus

A legfontosabb adatok

Ki végzi
Assiut University
Hol
Asyut (Egyiptom)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
90 fő, tervezett
Kezdés
2026. júl. 1.
Várható befejezés
2029. aug. 1.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Combined endoscopic third ventriculostomy & coroid plexus cauterization
A regiszteradat frissítve
2026. július 30.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for children with blocked-flow hydrocephalus (fluid build-up in the brain) seen on scans. They will have a combined endoscopic surgery (ETV with choroid plexus cauterization) as first treatment.

Életkor
Children below 18 years.
Nem
All sexes can join.
A betegség stádiuma
Obstructive hydrocephalus diagnosed on scans, including late onset aqueductal stenosis cases.
Korábbi kezelés
People who had a previous CSF diversion (such as a shunt) cannot join.

A részvétel fő kizáró okai

  • Communicating hydrocephalus
  • Acute bleeding inside the brain's fluid spaces
  • Active infection
  • Multilocular hydrocephalus (fluid in many separate pockets)
  • Previous CSF diversion

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki vehet részt

  • Children below 18 years
  • Radiologically diagnosed obstructive hydrocephalus
  • Late onset aqueductal stenosis cases

Ki nem vehet részt

  • Previous CSF diversion cases
  • Acute interventricular haemorrhage cases
  • Active infection cases
  • Communicating hydrocephalus
  • Multilocular hydrocephalus cases

Helyszínek itt: Egyiptom

  • Assuit University HospitalAsyut, EgyiptomContact: Ibraheem Ahmed Yosuf, Master degreeToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

Hydrocephalus remains one of the most common conditions encountered in neurosurgery, traditionally managed by ventriculoperitoneal (VP) shunting. Despite its effectiveness, shunt dependency is associated with certain complications including infection, obstruction, and repeated revisions, leading to increased morbidity and healthcare burden.

A teljes eredeti leírásKevesebb

Over the last 70 years, cerebrospinal fluid (CSF) shunting and more recently endoscopic third ventriculostomy (ETV) have been the mainstays of hydrocephalus treatment. In recent years, choroid plexus cauterization (CPC) has re-emerged as an additional treatment strategy.

In combination with ETV, CPC increases the chances of successfully treating some cases with hydrocephalus, than ETV alone.

Endoscopic Third Ventriculostomy (ETV) has emerged as an alternative physiological treatment by creating a bypass for cerebrospinal fluid (CSF) flow. However, its success is limited in infants and in other varieties of hydrocephalus. The addition of Choroid Plexus Cauterization (CPC), which reduces CSF production, has been shown to improve outcomes when combined with ETV, particularly in younger patients.

The idea is based on the principle that ablation of the predominant source of CSF secretion within the brain, choroid plexus (CP), reduces CSF production. In addition, CPC may reduce CSF pulsatility, an effect which may be potentiated when combined with ETV, which might reduce intraventricular pulsations by serving as a pulsation absorber. These effects, in combination, may tip the balance in favour of CSF absorption and negate the need for shunting in a proportion of patients.

The combined ETV-CPC approach, popularized by Benjamin Warf, has demonstrated promising results in reducing shunt dependence, especially in resource-limited settings. However, variability in success rates persists due to differences in patient selection, etiology, and surgical expertise.

This study aims at evaluation of the efficacy of combined ETV-CPC as a primary treatment modality for hydrocephalus and to identify predictors of surgical success and failure, thereby optimizing patient selection and improving outcomes.

A vizsgálat csoportja

  • Combined ETV & CPCA vizsgált kezelés

    1. History: A complete medical history will be taken from the mother, including age when diagnosed, history of NICU admission, history suggestive of infection, other congenital anomalies or family history and any neurological symptoms. 2. Through physical examination: * General examination including blood pressure, heart rate, respiratory rate, temprature. * Neurological examination especially for GCS, anterior fontanelle, head circumference, cranial nerve affection and mental and physical growth. * Visual assessment. 3. Investigations * Radiology: CT brain and/or MRI brain with CSF flowmetry. * Laboratory investigations like CBC, PT, PC,INR, renal enzymes and preoperative fitness. 4. Treatment modatities: Surgical strategy; ETV in combined with thermal cauterization of visible choroid plexus.

    Kezelés: Combined endoscopic third ventriculostomy & coroid plexus cauterization

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Efficacy of Combined Endoscopic Third Ventriculostomy and Choroid Plexus Cauterization as Primary Treatment for Paediatric Hydrocephalus
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. július 30.